Clinical Case Database / Category: Patient Management

Upper gastrointestinal cancer

Publication details

Gareth J Sadler MBChB BMedSci MRCP(UK), Gehanjali Amarasinghe BM MRCP(UK), Penny J Neild MD FRCP
Foundation Years Journal, volume 3, issue 4, p.9 (123Doc Education, London, May 2009)

Abstract

Oesophageal and gastric cancer are among the leading causes of cancer death in the United Kingdom (UK). This article provides an insight into the epidemiology, presentation, diagnosis and management of these conditions. It focuses specifically on the most common histological types of upper gastrointestinal malignancies, those of oesophageal squamous cell carcinoma and oesophageal adenocarcinoma and gastric adenocarcinoma.

Access the Clinical Cases Database

A subscription is required to read the full article. Please subscribe using one of the options below.

Authors

Gareth J Sadler MBChB BMedSci MRCP(UK)

Specialist Registrar in Gastroenterology
St George's Hospital
Tooting
London

Gehanjali Amarasinghe BM MRCP(UK)

Specialist Registrar in Gastroenterology
St George's Hospital
Tooting
London

Penny J Neild MD FRCP

Consultant Gastroenterologist
St George's Hospital
Tooting
London

References

1. Ellis FH Jr, Williamson WA, Heatley GJ. Cancer of the esophagus and cardia: Does age influence treatment selection and surgical outcomes? Journal of the American College of Surgeons, 1998, 187(4):345–351.
2. Arnott SJ, Duncan W, Gignoux M, et al. Preoperative radiotherapy in oesophageal carcinoma: A meta-analysis using individual patient data. International journal of radiation, oncology, biology, physics, 1998, 41(3):579–583.
3. Huang WZ, Fu JH, Hu Y, et al. Meta-analysis of postoperative adjuvant chemotherapy for localized oesophageal carcinoma. Ai Zheng, 2006, 25(10):1303–1306.
4. Gebski V, Burmeister B, Smithers BM, et al. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol, 2007, 8(3):226–234.
5. Fiorica F, Di Bona D, Schepis F, et al. Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis. Gut, 2004, 53:925–930.
6. Cooper JS, Guo MD, Herskovic A, et al. Chemoradiotherapy of locally advanced oesophageal cancer: long-term follow-up of a prospective randomized trial (RTOG-85-01). JAMA, 1999, 281(17):1623–1627.
7. Ell C, May A, Gossner L, et al. Endoscopic mucosal resection of early cancer and high grade dysplasia in Barrett's oesophagus. Gastroenterology, 2000, 118:670–677.
8. Shimizu Y, Tsukagoshi H, Fujita M, et al. Long-term outcome after endoscopic mucosal resection in patients with esophageal squamous cell carcinoma invading the muscularis mucosae or deeper. Gastrointest Endosc, September 2002, 56(3):387–390.
9. Wanebo HJ, Kennedy BJ, Chmiel J, et al. Cancer of the stomach. A patient care study by the American College of Surgeons. Ann Surg, November 1993, 218(5):583–592.
10. Bozzetti F, Marubini E, Bonfanti G, et al. Subtotal versus total gastrectomy for gastric cancer: five-year survival rates in a multicenter randomized Italian trial. Italian Gastrointestinal Tumour Study Group. Ann Surg, August 1999, 230(2):170–178.
11. Oñate-Ocaña LF, Aiello-Crocifoglio V, Mondragón-Sánchez R, et al. Survival benefit of D2 lympadenectomy in patients with gastric adenocarcinoma. Ann Surg Oncol, April 2000, 7(3):210–217.
12. Cuschieri A, Weeden S, Fielding J, et al. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group. Br J Cancer, 1999, 79(9–10):1522–1530.
13. Hartgrink HH, van de Velde CJ, Putter H, et al. Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. J Clin Oncol, 2004, 22(11):2069–2077.
14. Edwards P, Blackshaw GR, Lewis WG, et al. Prospective comparison of D1 vs modified D2 gastrectomy for carcinoma. Br J Cancer, 2004, 90(10):1888–1892.
15. Marubini E, Bozzetti F, Miceli R, et al. Lymphadenectomy in gastric cancer: prognostic role and therapeutic implications. Eur J Surg Oncol, 2002, 28(4):406–412.
16. Cunningham D, Allum WH, Stenning SP, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Eng J Med, 2006, 355(1):11–20.
17. Wagner AD, Grothe W, Behl S, et al. Chemotherapy for advanced gastric cancer (Review), 2008. Available for download at http://www.cochrane.org/reviews/en/ab004064.html
18. H Ono, H Kondo, T Gotoda, et al. Endoscopic mucosal resection for treatment of early gastric cancer. Gut, 2001, 48:225–229.
19. Wang Y, Bennett C, Pan T. Endoscopic mucosal resection for early gastric cancer, 2006. Available for download at http://www.cochrane.org/reviews/en/ab004276.html
20. Lin SZ, Tong HF, You T, et al. Palliative gastrectomy and chemotherapy for stage IV gastric cancer. J Cancer Res Clin Oncol, February 2008, 134(2):187–192.

Disclaimers

Conflict Of Interest

The Journal requires that authors disclose any potential conflict of interest that they may have. This is clearly stated in the Journal’s published “Guidelines for Authors”. The Journal follows the Guidelines against Conflict of Interest published in the Uniform Requirements for Manuscripts Submitted to Biomedical Journals (http://www.icmje.org/urm_full.pdf).

Financial Statement

The authors of this article have not been paid. The Journal is financed by subscriptions and advertising. The Journal does not receive money from any other sources. The decision to accept or refuse this article for publication was free from financial considerations and was solely the responsibility of the Editorial Panel and Editor-in-Chief.

Patient Consent statement

All pictures and investigations shown in this article are shown with the patients’ consent. We require Authors to maintain patients’ anonymity and to obtain consent to report investigations and pictures involving human subjects when anonymity may be compromised. The Journal follows the Guidelines of the Uniform Requirements for Manuscripts (http://www.icmje.org/urm_full.pdf). The Journal requires in its Guidelines for Authors a statement from Authors that “the subject gave informed consent”.

Animal & Human Rights

When reporting experiments on human subjects, the Journal requires authors to indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the HelsinkiDeclaration of 1975, as revised in 2008.

About the Clinical Cases Database

T​he Foundation Years Clinical Cases Database is​ a selection of 600 peer-reviewed clinical cases in the field of patient safety and clinical practice, specifically focused on the clinical information needs of junior doctors, based around the Foundation Year Curriculum programme (MMC). The cases have been chosen to align with the Foundation Year Curriculum.

The database is fully searchable, or can be browsed by medical specialty. Abstracts can be read free of charge, however a subscription is required in order to read the complete cases.